key: cord-0688463-0t8b8p75
authors: Shin, Hye-Rim; Kim, Baik-kyun; Lee, Soon-Tae; Kim, Aryun
title: Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
date: 2021-12-30
journal: J Clin Neurol
DOI: 10.3988/jcn.2022.18.1.114
sha: defd26bc81201db5fa387039466a7167498ea321
doc_id: 688463
cord_uid: 0t8b8p75

nan

bodies, and CSF oligoclonal band. Infection laboratory findings including for culturing and PCR were also all negative. She was not tested for antibodies against the SARS-CoV-2 virus. To explore the possibility of hidden cancer, chest and abdomen computed tomography as well as torso fluorodeoxyglucose positron-emission tomography were performed, but these findings were also normal. Follow-up cranial MRI performed 4 weeks after symptom onset showed no significant changes. We eventually started the patient on weekly rituximab, and she is monitored for further improvement.

The present case presented with autoimmune encephalitis after receiving the ChAdOx1 nCoV-19 vaccine. However, laboratory test results, including for autoimmune encephalitis antibodies, did not support the etiology.

Cases of autoimmune encephalitis secondary to COVID-19 infection have been reported previously. 2,3 Neurological symptoms in COVID-19 are attributed to interleukin-6, an important factor in the cytokine storm, or the presence of autoreactive antibodies targeting the central nervous system. Indeed, there are even cases of postinfectious encephalitis associated with anti-N-methyl-D-aspartate receptor (NMDAR) antibodies and anti-MOG antibodies in COVID-19 patients. 3, 4 Similarly, neurological complications following vaccination have also been well recognized. In particular, previous reports have shown that anti-NMDAR encephalitis can be associated with H1N1 influenza, tetanus, diphtheria, pertussis, and poliomyelitis vaccines. 5 Regarding the ChAdOx1 nCoV-19 vaccine, there have been cases of thrombotic thrombocytopenia and acute transverse myelitis as rare serious adverse events, which may be caused by the replication-deficient chimpanzee adenovirus adjuvant that the vaccine contains. 6, 7 We hypothesize that this rare clinical condition developed in our patient due to autoimmune activation by the ChAdOx1 nCoV-19 vaccine. This case report demonstrates that rare serious adverse events still have to be considered when administering COVID-19 vaccinations.

Video 1. The patient initially presented with severe rigidity, catatonia, and jaw-opening dystonia. Video 2. After intravenous high-dose steroid and immunoglobulin treatment, her catatonia, rigidity, and drooling improved partially. She could walk for a short distance without assistance, and her score on the modified Rankin Scale improved from 5 to 3.

The online-only Data Supplement is available with this article at https://doi.org/10.3988/jcn.2022.18.1.114.

The study was approved by Chungbuk National University Hospital's Institutional Review Board (2021-05-006-001). The patient provided informed consent to publish the manuscript and supplementary videos.

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request. 

Supervision: Soon-Tae Lee, Aryun Kim. Visualization: Baik-kyun Kim. Writing-original draft: Hye-Rim Shin, Aryun Kim. Writing-review & editing: Hye-Rim Shin, Baik-Kyun Kim

Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study

New-onset seizure with possible limbic encephalitis in a patient with COVID-19 infection: a case report and review

Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report

MOG-associated encephalitis following SARS-COV-2 infection

Anti-NMDA receptor encephalitis, vaccination and virus

Acute transverse myelitis (ATM): clinical review of 43 patients with COV-ID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222)

Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination

Hui-seong Kim (Division of Infectious Diseases, Department of Internal Medicine, Chungbuk National University Hospital) gave constructive opinion for the manuscript.

The authors have no potential conflicts of interest to disclose.

None